Orkambi is fixed-dose combination pill to treat cystic fibrosis in patients ≥ 12 years of age who are homozygous for the F508del mutation in the CFTR gene.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
Orkambi is fixed-dose combination pill to treat cystic fibrosis in patients ≥ 12 years of age who are homozygous for the F508del mutation in the CFTR gene.
If you have a Hayes login, click here to view the full report on the Knowledge Center.